Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Sci. STKE, 16 April 2002
Vol. 2002, Issue 128, p. tw139
[DOI: 10.1126/stke.2002.128.tw139]


Immunology Toll is a Coreceptor

Autoimmune diseases result from inappropriate activation of B cells by self-antigens. One of these antigens is chromatin, which is recognized by imunnoglobulin G2a (IgG2a). Leadbetter et al. studied B cell proliferation in cells from a mouse model for rheumatoid arthritis and systemic lupus erythematosus. The stimulation of proliferation of these B cells by DNA antigens required the B cell receptor and the Toll-receptor adapter MyD88. In the presence of agents that impair lysosome and endosome acidification, the cellular response to the Toll receptor TLR9 is impaired. The B cells failed to respond to DNA antigens in the presence of chloroquine, an agent that impairs acidification, thus implicating the TLR9 receptor in the activation of B cells by DNA-based autoantigens. The implications of these results for autoimmune disease are discussed by Vinuesa and Goodnow.

E. A. Leadbetter, I. R. Rifkin, A. M. Hohlbaum, B. C. Beaudette, M. J. Schlomchik, A. Marshak-Rothstein, Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416, 603-607 (2002). [Online Journal]

C. G. Vinuesa, C. C. Goodnow, DNA drives autoimmunity. Nature 416, 595-598 (2002). [Online Journal]

Citation: Toll is a Coreceptor. Sci. STKE 2002, tw139 (2002).

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882